Realizing the Promise of Neuromelanin-Sensitive MRI (NM-MRI)
Routine NM-MRI for individuals at risk of Parkinson's could provide a means of identifying the disease before symptoms emerge.
Sam Clark
Sam Clark, MD, PhD, founder and CEO of Terran Biosciences, is a multi-published neuroscientist and innovator with over 200 patent applications. With MD and PhD degrees from Columbia University and a BS in neuroscience from MIT, he founded Terran Biosciences to create a platform biotech company to transform the approach to therapeutics in neuropsychiatry. Terran has one of the largest psychedelic development programs in the industry and is a leader in medicinal and synthetic chemistry and novel approaches to the improvement and optimization of psychedelic compounds for patient use.